Divestments

HyTest

HyTest is a recognized producer of high-quality antibodies and antigens for the diagnostic industry all around the world

Founded in 1994 as a spinoff from a project within Turku University, HyTest is today a high-quality, global antibody and antigen manufacturer and supplier, primarily targeting in vitro diagnostics OEMS and research organizations. The company is headquartered in Turku.

  • Sector
    Healthcare
  • Country
    Finland
  • Fund
    EQT Mid-Market Credit,EQT Mid-Market Credit II
  • Entry
    2018
  • Exit
    2020-10-01

EQT Credit provided a Unitranche financing to support Summa Equity’s acquisition of HyTest, which is expected to benefit from the attractive market driven by non-cyclical, stable growth drivers.

To HyTest

Subscribe for the latest updates

Subscribe to EQT's press releases, regulatory press releases and updates.

Type of news
Preferred language
EQT logo
A purpose-driven global investment organization
© EQT AB 2022. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180